Skip to content

Clinical trials

Phase 3 Fetal Growth Retardation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fetal Growth Retardation Phase: Phase 3 Clear all

21 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20051
20091
20131
20152
20161
20173
20181
20192
20201
20211
20222
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Unknown status5
Recruiting3
Enrolling by invitation1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Ain Shams University3
Pfizer2
Assistance Publique - Hôpitaux de Paris1
Central Hospital, Nancy, France1
Centre Hospitalier Intercommunal Creteil1
Centre Hospitalier Universitaire de Saint Etienne1
Centro Hospitalar de Lisboa Central1
Fundació Sant Joan de Déu1
Hadassah Medical Organization1
Hospital Universitario 12 de Octubre1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fetal Growth Retardation21
Pre-Eclampsia7
Abruptio Placentae3
Perinatal Death3
Stillbirth3
Premature Birth2
Anemia, Sickle Cell1
Fetal Death1
Growth Disorders1
Pregnancy Complications1

Trials

Showing 76 to 21 of 21. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.